The LeAD Sports & Health Tech Accelerator in Lake Nona, Fla., has graduated five startups from its second annual program. The four-month accelerator concluded with a Demo Day earlier this month and saw the five startups receive commitments for 65% of their combined funding goals.
Twelve medical device startups finished the Massachusetts Medical Device Industry Council’s medtech accelerator program this week, with four of them winning cash prizes as part of the program.
MassMEDIC, the Massachusetts Medical Device Industry Council, announced today the successful conclusion of the 2021 program of its medtech accelerator focused on identifying and nurturing medical device leaders of the future, MedTech IGNITE. This year’s IGNITE cohort included 12 startups developing wearables, diagnostics, and surgical devices in the fields of neurology, women’s health, oncology, infectious disease, […]
This year’s IGNITE cohort included 12 startups developing wearables, diagnostics, and surgical devices in the fields of neurology, women’s health, oncology, infectious disease, diabetes, and cardiology.
The leAD Lake Nona Sports & Health Tech Accelerator did it again and presented outstanding sports & health tech startups at their Demo Day last Thursday. With Point, Suji, Kutai, Oxiwear, and Indifit, five stellar companies participated in and graduated from leAD’s second cohort in the U.S. The leAD Lake Nona Sports & Health Tech Accelerator is a […]
Lead Sports hosted the second demo day for its Lake Nona Sports & Health Tech Accelerator since the accelerator launched in 2020. Five startups from around the world showcased their innovative wellness and sports technologies, and also shared their plans for 2022, including fundraising, job growth and big-name partnerships.
Fresh off a pre-seed round led by prominent investors, OxiWear will build out its engineering team in Buffalo under CTO George Beckstein.
OxiWear, an Arlington-based company developing a wearable oxygen monitoring device, has raised a pre-seed funding round of $1.25 million, exceeding its goal of $750,000. This funding will allow the medical- and sports-technology startup to finish developing its product and start beta testing it before releasing the device by mid-year 2022.
The biotech’s oversubscribed pre-seed round included an investment from Halcyon Fund, which the nonprofit has not yet unveiled.
The device, also called OxiWear, attaches to the ear and can be worn 24 hours per day to measure oxygen saturation levels, called SPO2, and to detect when they begin to drop.
